Key Highlights

  • China Pharma Holdings (NYSEAMERICAN:CPHI) is listed at USD 0.75, which is 97% above its 52-week low of USD 0.38 and 96.1% below its high of USD 19.19.
  • China Pharma was contacted by NYSE American after unusual trading on July 10, 13 and 15, and said it knew of no material developments, after a 78.9% single-day gain on July 15.
  • It priced a USD 5 million registered direct offering of 2.5 million shares at USD 2.00 on July 22, and the stock at USD 0.75 is about 62% below that price.
  • The company has a late 10-K history, a reverse split approved in December and a patent acquisition in February, while the stock fell 13.47% on a USD 41.301 million market value.

The Latest Verified Updates

No company release dated October 13 was found in company filings and wire releases reviewed, so the most relevant recent updates are summarized here. China Pharma Holdings is a Haikou-based specialty pharmaceutical company with eight GMP-certified product lines, listed on NYSE American. NYSE American contacted the company over unusual trading on July 10, 13 and 15, and on July 15 and July 21 it said it knew of no material corporate developments, with the stock up 78.9% on July 15 and down 17.8% on July 21. On July 22 it priced a registered direct offering of 2.5 million shares at USD 2.00 for USD 5 million, with FT Global Capital as placement agent.

Why Trading Is Heavy and What the Data Says

Stockholders approved a reverse split and governance changes on December 30, 2025, and the company filed a late 10-K notice while showing narrowing losses. In February 2026 its Hainan Helpson unit acquired a patent to expand its R&D portfolio. The USD 0.75 price is about 62% below the USD 2.00 offering price from July, simple arithmetic, and the 52-week high of USD 19.19 shows how far the stock has fallen. Simple arithmetic puts the prior close near USD 0.87, so the day's move is about USD 0.12 a share. The price sits 97% above its 52-week low and 96.1% below its high, which frames how much of the range has already been used. The screen shows volume of 19.300 million shares against a three-month average of 5.466 million, or 3.5 times, and arithmetic on that volume implies traded value of about USD 14.5 million, or 0.4 times the market value. Identical volume figures have appeared on several earlier screens, so treat the field as carried over and rely on the drivers above for why the stock is active.

Risks and What to Watch

Spikes without news, small registered offerings and a late filing history make the stock prone to sharp reversals. What to watch next: the 10-K, further offerings and exchange notices. This is information only and not investment advice.

Where Things Stand

Market conditions frame the day: oil traded above USD 100, the big banks report this week and speculative technology names were under pressure. China Pharma Holdings (NYSEAMERICAN:CPHI) is moving with a fade after a news-free spike and a small offering. A drop on a stock this small and this volatile can reverse quickly, so the balance of evidence favors waiting for confirmation from filings and the next session. Direction remains unknown, and the next catalyst is the 10-K, further offerings and exchange notices. Check the underlying filings first, verify the latest filings before acting, and treat the figures as a snapshot.